$10.80
-0.46-4.04%
마지막 업데이트: Sep 23, 2:11 PM
Benzinga
Benzinga
Benzinga
수요일, 9월 23
Pharming Group
PHARNASDAQ
Pharming Earnings & Forecasts
Pharming (PHAR) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Pharming Guidance
Pharming (PHAR)는 7월 30, 2026에 fiscal year 2026에 대한 가이던스를 마지막으로 발표했습니다. 회사는 해당 기간의 매출을 $375M - $395M 범위로 예상했습니다.
이전 가이던스와 비교하여 Pharming는 매출 전망치를 이전 범위인 하향 조정됨에서 $405M - $425M로 상향 조정했습니다.
Pharming은 13과 1월 8, 2024 사이에 7월 30, 2026개의 지침 업데이트를 발표했습니다. During this period, the company raised its outlook 7 times and lowered it 1 time, providing investors with insight into management's evolving expectations.
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $0.09 | $0.01 | $0.07 | $0.02 |
| Actual | $0.02 | $-0.07 | $0.07 | $0.10 |
| Surprise | -77.8% | -800.0% | 0.00% | +400.0% |
| Revenue | ||||
| Estimate | $101.2M | $92.4M | $95.7M | $84.8M |
| Actual | $90.2M | $72.4M | $106.5M | $97.3M |
| Surprise | -10.8% | -21.6% | +11.2% | +14.8% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E | Q1 '27E |
|---|---|---|---|
| Earnings Per Share (Non-GAAP) | |||
| Consensus | $0.18 | $0.25 | $-0.10 |
| Revenue | |||
| Consensus | $103.4M | $115.6M | — |
Earnings & Guidance News
Benzinga
© 2026 Benzinga | All Rights Reserved